NFL

NFL and NFLPA Launch Joint Review into Jalen Hurts' Medical Handling

  • Authored By: Sports Now
  • Updated Oct 25, 2026, 20:52 IST

The NFL and the players' union have initiated a joint review regarding the medical management of Jalen Hurts' blood clot diagnosis, which has ruled the quarterback out for the remainder of the season.

NFL and NFLPA Launch Joint Review into Jalen Hurts' Medical Handling

The NFL and the NFL Players Association have officially launched a collaborative review into the medical procedures surrounding Jalen Hurts' recent blood clot diagnosis. This joint investigation follows a formal request from the NFLPA earlier in the week, prompting both parties to examine the sequence of events leading to the Philadelphia Eagles quarterback being placed on injured reserve.

Hurts, the reigning Super Bowl LIX MVP, is expected to remain sidelined for the duration of the season. His medical condition was confirmed by the Eagles and his agent, Nicole Lynn, as deep vein thrombosis accompanied by bilateral pulmonary emboli. The quarterback is currently undergoing treatment with blood thinners and has been restricted from all football-related activities until he is cleared from this medication.

Timeline of Medical Evaluation and Protocol

The situation originated on October 4, when Hurts sustained a calf injury after being struck by a cleat during a matchup against the Los Angeles Rams. He subsequently reported the injury to the team's medical staff on October 8. Despite the injury, Hurts returned to practice the following day before the team traveled to London for their international fixture against the Jacksonville Jaguars.

While in London, specialists initially diagnosed the quarterback with a superficial vein thrombosis in his left calf. Following this evaluation, Hurts participated in the game against Jacksonville on October 11. The subsequent discovery that the clot had traveled to his lungs has triggered this comprehensive review of the medical protocols followed by the organization.

League Response and Medical Defense

NFL Commissioner Roger Goodell addressed the matter on Wednesday, confirming that the league supports the investigation. Goodell expressed confidence in the existing medical protocols, noting that the league’s chief medical officer, Dr. Allen Sills, has already provided a defense of the Eagles' medical staff. According to the Commissioner, the league believes the established processes were followed correctly during the evaluation period.

The joint review aims to ensure that all medical standards were upheld throughout the timeline of the injury. As the investigation proceeds, the focus remains on the adherence to league-wide health and safety protocols during the period between the initial calf injury and the subsequent diagnosis of pulmonary emboli.